Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KOD Kodiak Sciences > Detailed Quotes

KOD Kodiak Sciences

7.980
-0.550-6.45%
Close 09/23 16:00 ET
7.9800.0000.00%
Post Mkt Price 09/23 16:01 ET
High
8.430
Open
8.430
Turnover
3.21M
Low
7.910
Pre Close
8.530
Volume
397.54K
Market Cap
415.28M
P/E(TTM)
Loss
52wk High
131.970
Shares
52.04M
P/E(Static)
Loss
52wk Low
4.900
Float Cap
248.44M
Bid/Ask %
17.65%
Historical High
171.210
Shs Float
31.13M
Volume Ratio
0.78
Historical Low
4.900
Dividend TTM
--
Div Yield TTM
250
P/B
0.78
Dividend LFY
--
Div Yield LFY
3132.83%
Turnover Ratio
1.28%
Amplitude
6.10%
Avg Price
8.072
Lot Size
1
Float Cap
248.44M
Bid/Ask %
17.65%
Historical High
171.210
Shs Float
31.13M
Volume Ratio
0.78
Historical Low
4.900
Dividend TTM
--
P/B
0.78
Dividend LFY
--
Turnover Ratio
1.28%
Amplitude
6.10%
Avg Price
8.072
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
CEO: Dr. Victor Perlroth, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...